The Zenith Drugs IPO commenced on February 19, 2024, and concluded on February 22, 2024. The allotment of shares took place on February 23, 2024, and the initiation of refunds began on February 26, 2024. The shares were credited to the demat accounts of investors on February 26, 2024. Finally, the listing of Zenith Drugs on the stock exchange occurred on February 27, 2024.
The Zenith Drugs IPO was priced at ₹75 to ₹79 per share, with a lot size of 1600 shares. The total issue size was ₹40.68 crores, comprising a fresh issue of ₹40.68 crores. The IPO was listed on the NSE SME.
In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.
Zenith Drugs IPO Basic Details
| Company Name | Zenith Drugs Limited |
| Domain of Company | Pharma Company |
| Zenith Drugs IPO GMP Today | ₹7 |
| Zenith Drugs IPO Listing Gain | 8.86% |
| Zenith Drugs IPO Open Date | February 19, 2024 |
| Zenith Drugs IPO Close Date | February 22, 2024 |
| Zenith Drugs IPO Allotment Date | February 23, 2024 |
| Zenith Drugs IPO Listing Date | February 27, 2024 |
| Face Value | ₹10 per share |
| Price | ₹75 to ₹79 per share |
| Lot Size | 1600 Shares |
| Issue Size | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Fresh Issue | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi |
Zenith Drugs IPO GMP Today:
| Date | GMP | Listing Gain | Kostak | Subject to |
| Today | ₹7 | 8.86% | – | – |
| 16 February 2024 | ₹7 | 8.86% | – | – |
Zenith Drugs IPO Details:
Founded in the year 2000, Zenith Drugs Limited stands as a pharmaceutical company dedicated to producing and supplying high-quality and affordable medicines, including generic drugs.
We prioritize quality by adhering to WHO-GMP guidelines and obtaining ISO 9001:2015 certification from a reputable EuroUK certification body.
Our diverse product range encompasses ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. With the approval of over 600 products by the Food & Drugs Administration, 325 are actively in production.
Excitingly, we are currently establishing a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh, to enhance our production capabilities.
Our products reach various countries, including Costa Rica in Central America, the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
Zenith Drugs Limited is a specialist in third-party manufacturing, also known as white label manufacturing. We proudly serve esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, Zest Pharma, and more.
As of March 31, 2023, our dedicated team comprises 89 employees, with 61 on payroll and 28 on contract.
Zenith Drugs IPO More Details Click Here
Zenith Drugs IPO FAQs
When is Zenith Drugs IPO open?
Zenith Drugs IPO will open on 19 February 2024.
When is Zenith Drugs IPO Close?
Zenith Drugs IPO will be closed on 22 February 2024.
What is Zenith Drugs IPO GMP Today?
The Zenith Drugs IPO GMP aka Grey Market Premium is ₹7.
What is Zenith Drugs IPO Kostak Rates Today?
The Zenith Drugs IPO Kostak Rate is ₹000.
What is Zenith Drugs IPO Subject to Sauda Price Today?
The Zenith Drugs IPO subject to sauda rates is ₹000.
Zenith Drugs IPO Expected Returns?
The Zenith Drugs expected return is 8.86%.
How much will be the listing gain in Zenith Drugs IPO?
Zenith Drugs IPO will get listing gain of 8.86%. (Approx.)
